IFIH1 and dermatomyositis: Several potential parameters for distinguishing anti-MDA5 DM RPILD from anti-MDA5 DM non-RPILD and predicting survival in anti-MDA5 DM patients have been found, including demographics, imaging features, and laboratory indicators (17–21).